These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9570012)

  • 1. Regulation of gene expression, growth, and cell survival by IL-4: contribution of multiple signaling pathways.
    Keegan AD; Zamorano J
    Cell Res; 1998 Mar; 8(1):1-13. PubMed ID: 9570012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on interleukin-4 and its receptor.
    Chomarat P; Banchereau J
    Eur Cytokine Netw; 1997 Dec; 8(4):333-44. PubMed ID: 9459612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-4 (IL-4) pathway.
    Kelly-Welch A; Hanson EM; Keegan AD
    Sci STKE; 2005 Jul; 2005(293):cm9. PubMed ID: 16030287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-13 (IL-13) pathway.
    Kelly-Welch A; Hanson EM; Keegan AD
    Sci STKE; 2005 Jul; 2005(293):cm8. PubMed ID: 16030286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Function, molecular structure and gene expression of IL-4].
    Noma T
    Nihon Rinsho; 1992 Aug; 50(8):1787-94. PubMed ID: 1433969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic functions and signaling of the interleukin-4 receptor complexes.
    Gessner A; Röllinghoff M
    Immunobiology; 2000 Jan; 201(3-4):285-307. PubMed ID: 10776786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor.
    Gauchat JF; Schlagenhauf E; Feng NP; Moser R; Yamage M; Jeannin P; Alouani S; Elson G; Notarangelo LD; Wells T; Eugster HP; Bonnefoy JY
    Eur J Immunol; 1997 Apr; 27(4):971-8. PubMed ID: 9130652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
    Rahaman SO; Sharma P; Harbor PC; Aman MJ; Vogelbaum MA; Haque SJ
    Cancer Res; 2002 Feb; 62(4):1103-9. PubMed ID: 11861389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sharing of receptor subunits and signal transduction pathway between the IL-4 and IL-13 receptor system.
    Murata T; Taguchi J; Puri RK; Mohri H
    Int J Hematol; 1999 Jan; 69(1):13-20. PubMed ID: 10641437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 4 receptor: signaling mechanisms.
    Keegan AD; Nelms K; Wang LM; Pierce JH; Paul WE
    Immunol Today; 1994 Sep; 15(9):423-32. PubMed ID: 7945783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma and interleukin-4 regulate T cell interleukin-12 responsiveness through the differential modulation of high-affinity interleukin-12 receptor expression.
    Gollob JA; Kawasaki H; Ritz J
    Eur J Immunol; 1997 Mar; 27(3):647-52. PubMed ID: 9079804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine regulation of mucus production in a model of allergic asthma.
    Cohn L; Whittaker L; Niu N; Homer RJ
    Novartis Found Symp; 2002; 248():201-13; discussion 213-20, 277-82. PubMed ID: 12568496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of interleukin 4 receptor expression on human lymphoid cells by cyclosporin.
    Foxwell BM; Woerly G; Ryffel B
    Eur J Immunol; 1990 May; 20(5):1185-8. PubMed ID: 2141571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptanthrin inhibits Th2 development, and IgE-mediated degranulation and IL-4 production by rat basophilic leukemia RBL-2H3 cells.
    Iwaki K; Ohashi E; Arai N; Kohno K; Ushio S; Taniguchi M; Fukuda S
    J Ethnopharmacol; 2011 Mar; 134(2):450-9. PubMed ID: 21216280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of PtdIns-3-kinase and the guanine nucleotide binding proteins p21ras during signal transduction by the T cell antigen receptor and the interleukin-2 receptor.
    Cantrell DA; Izquierdo M; Reif K; Woodrow M
    Semin Immunol; 1993 Oct; 5(5):319-26. PubMed ID: 8260648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 4 receptors on normal human B lymphocytes: characterization and regulation.
    Zuber CE; Galizzi JP; Vallé A; Harada N; Howard M; Banchereau J
    Eur J Immunol; 1990 Mar; 20(3):551-5. PubMed ID: 2318249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4-dependent induction of BCL-2 and BCL-X(L)IN activated T lymphocytes through a STAT6- and pi 3-kinase-independent pathway.
    Aronica MA; Goenka S; Boothby M
    Cytokine; 2000 Jun; 12(6):578-87. PubMed ID: 10843732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13.
    Serve H; Oelmann E; Herweg A; Oberberg D; Serve S; Reufi B; Mücke C; Minty A; Thiel E; Berdel WE
    Cancer Res; 1996 Aug; 56(15):3583-8. PubMed ID: 8758930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-interleukin-4 therapy.
    Steinke JW
    Immunol Allergy Clin North Am; 2004 Nov; 24(4):599-614, vi. PubMed ID: 15474861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
    Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
    Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.